Cardiac dysfunction in Duchenne's

heart disease
Credit: CC0 Public Domain

Duchenne muscular dystrophy (DMD) is a severe muscle disease that causes progressive muscle weakening and degeneration.

Cardiomyopathy is the leading cause of death in DMD, but standard markers of heart failure are poor indicators of disease. Determining factors involved in DMD cardiomyopathy could identify novel biomarkers to follow disease progression and as targets for drug therapy.

DMD cardiomyopathy appears to result from progressive myocardial fibrosis, or scar formation. Jonathan Soslow, MD, MSCI, and colleagues explored a role for proteins called MMPs and TIMPs that regulate the extracellular matrix—the connective tissue between cells.

They found elevated of three MMPs in patients with DMD compared to controls. One of these, MMP7, was higher in DMD patients with as determined by cardiac MRI.

The findings, reported in the Journal of Cardiac Failure, suggest a role for MMP7 in DMD myocardial fibrosis and support further study of MMP7 as a potential biomarker of cardiovascular disease severity.

Explore further

Heart muscle disease patients benefit from defibrillator

More information: Jonathan H, Soslow et al. The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Duchenne Muscular Dystrophy Cardiomyopathy, Journal of Cardiac Failure (2019). DOI: 10.1016/j.cardfail.2019.02.006
Citation: Cardiac dysfunction in Duchenne's (2019, April 5) retrieved 21 October 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more